Lista de obras -

5-Fluorouracil or gemcitabine combined with adenoviral-mediated reintroduction of p16INK4A greatly enhanced cytotoxicity in Panc-1 pancreatic adenocarcinoma cells

artículo científico publicado en 2004

A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case-control study

scientific article published on 10 December 2020

A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer

artículo científico publicado en 2021

Biomarkers for early diagnosis of pancreatic cancer

artículo científico publicado en 2014

Confounding effect of obstructive jaundice in the interpretation of proteomic plasma profiling data for pancreatic cancer

artículo científico publicado en 2009

Cytoplasmic HuR Status Predicts Disease-free Survival in Resected Pancreatic Cancer: A Post-hoc Analysis From the International Phase III ESPAC-3 Clinical Trial.

artículo científico publicado en 2016

Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes Mellitus

artículo científico publicado en 2015

Designing a bio-inspired biomimetic in vitro system for the optimization of ex vivo studies of pancreatic cancer

artículo científico publicado en 2017

Diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissue

artículo científico publicado en 2012

Early Epigenetic Downregulation of microRNA-192 Expression Promotes Pancreatic Cancer Progression

artículo científico publicado en 2016

Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice

artículo científico publicado en 2016

Fibroblasts from distinct pancreatic pathologies exhibit disease-specific properties

scientific article published on 11 May 2020

GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer

artículo científico publicado en 2016

Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial

artículo científico publicado en 2014

Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium

artículo científico publicado en 2012

High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients

artículo científico publicado en 2005

Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma

artículo científico publicado en 2015

Immune Cell and Stromal Signature Associated With Progression-Free Survival of Patients With Resected Pancreatic Ductal Adenocarcinoma

artículo científico publicado en 2018

Immunobiological effects of gemcitabine and capecitabine combination chemotherapy in advanced pancreatic ductal adenocarcinoma

artículo científico publicado en 2016

Lack of Association for Reported Endocrine Pancreatic Cancer Risk Loci in the PANDoRA Consortium

artículo científico publicado en 2017

Low molecular weight heat shock protein HSP27 is a prognostic indicator in rectal cancer but not colon cancer

artículo científico publicado en 2010

New biomarkers and targets in pancreatic cancer and their application to treatment

artículo científico

New treatment options for advanced pancreatic cancer

scientific article published on October 2008

Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial

artículo científico publicado en 2013

Pancreatic cancer risk in relation to lifetime smoking patterns, tobacco type, and dose-response relationships

scientific article published on 12 February 2020

Pancreatic cancer susceptibility loci and their role in survival

artículo científico publicado en 2011

Pancreatic mass in a young CFTR carrier with a heterozygous p.R117H CFTR gene mutation and homozygous 7T.

artículo científico publicado en 2015

Reduced risk of pancreatic cancer associated with asthma and nasal allergies.

artículo científico publicado en 2015

Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease

artículo científico publicado en 2014

Somatic mutations in exocrine pancreatic tumors: association with patient survival

artículo científico publicado en 2013

The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic cancer

artículo científico publicado en 2016

Therapeutic developments in pancreatic cancer: current and future perspectives

artículo científico publicado en 2018

Transcriptional variations in the wider peritumoral tissue environment of pancreatic cancer

artículo científico publicado en 2017

UHRF1 regulation of the Keap1-Nrf2 pathway in pancreatic cancer contributes to oncogenesis

artículo científico publicado en 2015

Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial.

artículo científico publicado en 2017

Lista de obras de

5-Fluorouracil or gemcitabine combined with adenoviral-mediated reintroduction of p16INK4A greatly enhanced cytotoxicity in Panc-1 pancreatic adenocarcinoma cells

A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case-control study

A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer

Biomarkers for early diagnosis of pancreatic cancer

Confounding effect of obstructive jaundice in the interpretation of proteomic plasma profiling data for pancreatic cancer

Cytoplasmic HuR Status Predicts Disease-free Survival in Resected Pancreatic Cancer: A Post-hoc Analysis From the International Phase III ESPAC-3 Clinical Trial.

Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes Mellitus

Designing a bio-inspired biomimetic in vitro system for the optimization of ex vivo studies of pancreatic cancer

Diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissue

Early Epigenetic Downregulation of microRNA-192 Expression Promotes Pancreatic Cancer Progression

Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice

Fibroblasts from distinct pancreatic pathologies exhibit disease-specific properties

GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer

Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial

Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium

High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients

Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma

Immune Cell and Stromal Signature Associated With Progression-Free Survival of Patients With Resected Pancreatic Ductal Adenocarcinoma

Immunobiological effects of gemcitabine and capecitabine combination chemotherapy in advanced pancreatic ductal adenocarcinoma

Lack of Association for Reported Endocrine Pancreatic Cancer Risk Loci in the PANDoRA Consortium

Low molecular weight heat shock protein HSP27 is a prognostic indicator in rectal cancer but not colon cancer

New biomarkers and targets in pancreatic cancer and their application to treatment

New treatment options for advanced pancreatic cancer

Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial

Pancreatic cancer risk in relation to lifetime smoking patterns, tobacco type, and dose-response relationships

Pancreatic cancer susceptibility loci and their role in survival

Pancreatic mass in a young CFTR carrier with a heterozygous p.R117H CFTR gene mutation and homozygous 7T.

Reduced risk of pancreatic cancer associated with asthma and nasal allergies.

Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease

Somatic mutations in exocrine pancreatic tumors: association with patient survival

The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic cancer

Therapeutic developments in pancreatic cancer: current and future perspectives

Transcriptional variations in the wider peritumoral tissue environment of pancreatic cancer

UHRF1 regulation of the Keap1-Nrf2 pathway in pancreatic cancer contributes to oncogenesis

Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial.